title: Could cytogenetics and minimal residual disease replace conventional risk criteria in adults with Ph-negative acute lymphoblastic leukaemia?
authors.forename: Sebastian
authors.initials: S
authors.lastname: Giebel
authors.forename: Malgorzata
authors.initials: M
authors.lastname: Krawczyk-Kulis
authors.forename: Slawomira
authors.initials: S
authors.lastname: Kyrcz-Krzemien
authors.forename: Olga
authors.initials: O
authors.lastname: Haus
authors.forename: Krystyna
authors.initials: K
authors.lastname: Jagoda
authors.forename: Beata
authors.initials: B
authors.lastname: Piatkowska-Jakubas
authors.forename: Monika
authors.initials: M
authors.lastname: Paluszewska
authors.forename: Ilona
authors.initials: I
authors.lastname: Seferynska
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Chrobok
authors.forename: Beata
authors.initials: B
authors.lastname: Stella-Holowiecka
authors.forename: Marek
authors.initials: M
authors.lastname: Kielbinski
authors.forename: Jerzy
authors.initials: J
authors.lastname: Holowiecki
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D006801:Humans; D007621:Karyotyping; D008875:Middle Aged; D018365:Neoplasm, Residual / Q000235:genetics / Q000473:pathology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics / Q000473:pathology*; D011379:Prognosis; D012008:Recurrence; D055815:Young Adult